Blackhawk Growth Corp. is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. We look for opportunities all over the globe where we can leverage our knowledge, expertise, and experience to deliver substantial growth for our companies and our investors.
Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company’s strategy is focused on investing in multiple companies across a variety of sectors across North America.
Trip Pharma intends to be a leader in researching the use of psilocybin as an alternative medical treatment, MDMA and other peripheral substances through its application for a Controlled Drugs and Substances Dealers License.
Medigen Biotechnology Corp. & TBG Biotechnology Corp.
Blackhawk’s license with Medigen and TBG allow the company to sell COVID-19 Rapid test kits used in the detection of antibodies associated with COVID-19. Both testing kits are EUA approved by the FDA.
Sac Pharma is an established California based cannabis cultivation company. With proprietary recipes and formulas, high demand strains, and key distributor relationships, the well-established team at Sac Pharma not only grows a product that looks and smells good but sells just as well. Consistently outperforming its peers, Sac Pharma offers high-end bulk product that is sold before each harvest.
Spaced Food produces and will sell shelf-stable, cannabis-infused edibles that require no refrigeration. This intellectual property can be applied to almost anything. Current products range from cheesecake to ice cream and even cannabis-infused fruits and berries.
We look for opportunities all over the globe where we can leverage our knowledge, expertise and experience to deliver substantial growth for our companies and our investors.